Let DRA’s Languages and Communication Team take care of writing high-quality medical texts for your pharmaceutical products. Translations by our expert team combine fluent language with medical and pharmacological expertise, as well as knowledge of administrative regulations, official guidelines and QRD templates. We can also help you with medical content or marketing compliance reviews.
Our translation and communication services include:
- Product information (PI) translations and updates (SmPC, PL, labelling)
- Marketing materials and web pages
- Educational materials, standard operating procedures (SOPs) and articles
- Risk management materials (RMP) and DHPC documents
- Clinical trial documentation
- Reviews of texts and factual content (medical review, linguistic review, quality review).
DRAs experienced native-speaking pharma translators have several years of experience in medical translations. They are familiar with EMA QRD templates, referral and PRAC wordings and standard terms, as well as EMA guidelines, marketing legislation, regulations and the industry’s Code of Ethics. The team works in a close cooperation with DRA’s in-house pharmacological experts and promotional material experts.
The team’s Key Performance Indicators are monitored monthly and the results show high quality and guaranteed on-time delivery. DRA’s translation team constantly receives positive feedback for their superior performance.
We ensure that facts and figures are accurate down to the smallest detail and that the style matches the target group. Remember that clear, stylistically appropriate language is part of a positive corporate image! High-quality translations also speed up your application process and promote safe use of medicines.
Cooperation will make the Nordic region an attractive pharmaceutical market
In the global pharmaceutical market, the individual Nordic countries are very small. Together, they are much larger, but still relatively lightweight. This is certainly true if you look purely at sales volumes.
Our growth story continues – DRA Consulting to become part of the PharmaLex Group
DRA and PharmaLex are merging to create a centre of pharma and Health Tech expertise with nearly 3,000 experts. The merger will bring synergies for the customers of both companies while helping to accelerate Nordic cooperation in the pharmaceutical market.